Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Debt / NOTE 11/0
-
Number of holders
-
23
-
Total 13F principal, excl. options
-
556M
-
Principal change
-
-6.23M
-
Total reported value, excl. options
-
$544M
-
Value change
-
-$6.06M
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$0.98
Significant Holders of NOVOCURE LTD - NOTE 11/0 as of Q2 2025
23 filings reported holding 67011XAB9 - NOVOCURE LTD - NOTE 11/0 as of Q2 2025.
NOVOCURE LTD - NOTE 11/0 has 23 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $556M of principal
.
Largest 10 bondholders include BRAIDWELL LP ($141M of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($97.7M of principal), Opti Capital Management, LP ($74.8M of principal), DeepCurrents Investment Group LLC ($69.5M of principal), Voya Investment Management LLC ($64.5M of principal), MILLENNIUM MANAGEMENT LLC ($35.4M of principal), Linden Advisors LP ($35M of principal), BNP PARIBAS FINANCIAL MARKETS ($11M of principal), STATE STREET CORP ($10.7M of principal), and Kohlberg Kravis Roberts & Co. L.P. ($3.85M of principal).
This table shows the top 23 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.